CoQ10 and sleep quality

What sleep and vigor studies showed and what is known about tolerability.

Key points

  • In healthy working adults aged 30–64, ubiquinol showed no convincing advantage over placebo in self-rated sleep for the whole group over eight weeks. This trial did not demonstrate a confirmed improvement in sleep. [1] See the evidence 1
  • Mild insomnia has been reported with CoQ10. If sleep worsens after starting it, discuss the supplement with a healthcare professional. [2] See the evidence 1
  • In a separate eight-week study of healthy adults aged 40 and over, neither ubiquinone nor ubiquinol showed a convincing advantage in vigor. Sleep and vigor were assessed separately. [3] See the evidence 1

Practical guide

Check the conclusions and whether they apply to your situation.

Sleep and daytime vigor are assessed with different measures.

Key points

Why these conclusions

Sleep and vigor

Healthy working adults aged 30–64 received 100 mg of ubiquinol daily or placebo for eight weeks. No convincing advantage in self-rated sleep was found in the whole group. [1]

In a separate study of healthy adults aged 40 and over, 200 mg of ubiquinone or ubiquinol with food showed no convincing advantage over placebo in vigor over eight weeks. [3]

Mild insomnia and gastrointestinal disturbances are reported; short RCTs do not establish rare or long-term risks. [2]

In healthy working adults over eight weeks, no convincing advantage of ubiquinol in self-rated sleep was found in the whole group.

ParameterData
ResultIn healthy working adults over eight weeks, no convincing advantage of ubiquinol in self-rated sleep was found in the whole group. No significant advantage was found in the overall analysis; a subgroup signal in stress-sensitive participants does not establish an overall effect.
Participants60 healthy working adults aged 30–64; 52 in the efficacy analysis (24 versus 28)
Form100 mg/day ubiquinol
Dose100 mg/day ubiquinol
Dose basis100 mg/day ubiquinol
ComparatorPlacebo
Duration8 weeks
Confidence2/4: Precision: No exact confidence interval for the overall contrast. Consistency: No grounds for a separate downgrade. Applicability to the specified group: The study tested the stated form, participant group and outcome. Possible publication bias: No specific data for a separate downgrade. Study methods: 52 of 60 in the analysis, exploratory subgroup.
Evidence base1 trial; outcome from the same participant group
Sources[1]

Mild insomnia and gastrointestinal disturbances are reported; short RCTs do not establish rare or long-term risks.

Mild insomnia and gastrointestinal disturbances are reported; short RCTs do not establish rare or long-term risks. [2]

In healthy adults aged 40 and over, neither ubiquinone nor ubiquinol showed a convincing advantage in vigor ratings over eight weeks.

ParameterData
ResultIn healthy adults aged 40 and over, neither ubiquinone nor ubiquinol showed a convincing advantage in vigor ratings over eight weeks. No significant advantage was reported. The main text gives p>0.44 for secondary outcomes; the abstract gives p>0.16.
Participants150 healthy adults aged 40 and over allocated to five groups
Form200 mg/day ubiquinone or 200 mg/day ubiquinol, separate groups, with food
Dose200 mg/day ubiquinone or 200 mg/day ubiquinol, separate groups, with food
Dose basis200 mg/day ubiquinone or 200 mg/day ubiquinol, separate groups, with food
ComparatorPlacebo
Duration8 weeks
Confidence2/4: Precision: Exact confidence intervals for each form versus placebo were not extracted. Consistency: No grounds for a separate downgrade. Applicability to the specified group: The study tested the stated form, participant group and outcome. Possible publication bias: No specific data for a separate downgrade. Study methods: Multiple secondary measures in five groups.
Evidence base1 trial; outcome from the same participant group
Sources[3]

More details

What was assessed

Self-rated sleep and vigor are separate outcomes in different groups. [1] [3]

Sources

  1. Reduced Form of Coenzyme Q10 Relieves Daily Life Stress and Improves Sleep Quality in Healthy Subjects with High Stress Sensitivity. https://www.ubiquinol.net.au/wp-content/uploads/2025/03/KanekaUbiquinol_Research-paper_Endurance-and-recovery_-Ubiquinol-improves-sleep-quality_Morikawa_HCP_2019.pdf
  2. Coenzyme Q10 | NCCIH. https://www.nccih.nih.gov/health/coenzyme-q10
  3. A Randomized, Double-Blind, Placebo-Controlled Trial Comparing the Effects of Commercially Available Ubiquinone, Ubiquinol, and Geranylgeraniol Dietary Supplements on Plasma CoQ10 Concentrations. https://doi.org/10.1155/jnme/5589963

Methodology: Subpages evidence-led supplement pipeline v1

Ingredient overview: Ubidecarenone